Kelly Louise Morrison, U.S. Representative

Kelly Louise Morrison

DemocratMN03houseFiled Jun 18, 2025

Kelly Louise Morrison (D-MN) sold $15K-$50K of $ZBRA (Zebra Technologies Corporation Class A Common Stock) on Jun 4, 2025, part of 19 transactions in this filing (2 buys, 17 sells).

HillSignal flagged 2 timing concerns on this filing — trades that line up closely with related legislative or contract activity.

Transactions
19
Companies
6
Largest Trade
$15K-$50K
Timing Flags
2

Companies in this filing · 6

Price Movement Since Trade

How the largest positions have moved from the trade date to the most recent close.

Suspicious Timing Detected

2 flags
1.

Rep. Kelly Louise Morrison sold $1,001 - $15,000 in $UPS on 2025-06-04 — 91 days before the 'Stop Chinese Fentanyl Act of 2025' (HR747) was introduced, a bill that expands sanctions on Chinese entities involved in opioid and precursor production.

2.

Rep. Kelly Louise Morrison sold $1,001 - $15,000 in $UPS on 2025-06-04 — 56 days after the 'Protecting Employees and Retirees in Business Bankruptcies Act of 2025' (S1381) was introduced, a bill aiming to increase corporate liability.

These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.

Share This Filing

All Transactions

BUY$1K-$15K
Government SecuritiesCHASKA MN ELEC REVENUE REF - SER A DTD 10/01/15
Apr 1, 2025 \u2022 unknown
BUY$1K-$15K
Government SecuritiesMINNESOTA ST MUNI PWR AGY ELEC DTD 08/25/16
Apr 1, 2025 \u2022 unknown
SELL$15K-$50K
$ZBRAZebra Technologies Corporation Class A Common Stock
$291.03 \u2192 N/A
Jun 4, 2025 \u2022 unknown
SELL$1K-$15K
$HLIHoulihan Lokey, Inc. Class A Common Stock
$174.02 \u2192 N/A
Jun 4, 2025 \u2022 unknown
SELL$1K-$15K
$NKENike, Inc. Common Stock
$62.77 \u2192 N/A
Jun 4, 2025 \u2022 unknown
SELL$1K-$15K
$NKENike, Inc. Common Stock
$62.77 \u2192 N/A
Jun 4, 2025 \u2022 unknown
SELL$1K-$15K
$RMDResMed Inc. Common Stock
$249.94 \u2192 N/A
Jun 4, 2025 \u2022 unknown
SELL$1K-$15K
$RMDResMed Inc. Common Stock
$249.94 \u2192 N/A
Jun 4, 2025 \u2022 unknown
SELL$1K-$15K
$RMDResMed Inc. Common Stock
$249.94 \u2192 N/A
Jun 4, 2025 \u2022 unknown
SELL$1K-$15K
$RMDResMed Inc. Common Stock
$249.94 \u2192 N/A
Jun 4, 2025 \u2022 unknown

Connected Legislative Activity

4 signals

These bills and contracts share tickers or sectors with this filing's trades.

BillS2056bullish

CREATE JOBS Act

The CREATE JOBS Act (S.2056) proposes permanently reinstating 100% bonus depreciation for all U.S. businesses, a proven tax incentive reducing the after-tax cost of capital equipment by 21% in year one. At current market prices, capital-intensive companies like CAT ($810.05), DE ($560.02), FDX ($388.59), and AMZN ($263.04) have already shown strong 30-day momentum (CAT +21.37%, FDX +13.7%, AMZN +30.9%), reflecting broader economic expectations this tax policy reinforces. The bill is in early committee stage with legislative risk high, but identical House companion HR3967 improves odds of eventual enactment.

Jun 12, 2025
AMZNCATDEFDXGEVPLD
BillS2677neutral

A bill to expand the sharing of information with respect to suspected violations of intellectual property rights in trade.

S.2677 is an early-stage procedural bill that expands CBP's authority to share IP violation data with rights holders. It imposes minimal compliance obligations on marketplaces and carriers but has zero appropriated funding. This bill has no material market-moving potential for any company. Retail investors should ignore this legislation for trading decisions.

Aug 1, 2025
EBAYFDXNKE
BillS1381bearish

Protecting Employees and Retirees in Business Bankruptcies Act of 2025

S. 1381 (Protecting Employees and Retirees in Business Bankruptcies Act of 2025) is an early-stage Senate bill that would structurally increase bankruptcy costs for labor-intensive companies. For UAL and GM, the bill elevates employee and retiree claims in Chapter 11, raising bankruptcy risk premiums. At impact score 3, near-term market effects are minimal, but the structural risk is real if the bill advances through the Judiciary Committee.

Apr 9, 2025
GMUAL
BillHR747bearish

Stop Chinese Fentanyl Act of 2025

HR747 (Stop Chinese Fentanyl Act) is an early-stage House bill expanding sanctions definitions for Chinese entities involved in opioid precursors. The bill has been reported by committee but faces a long legislative path. Market data shows chemicals ($DD, $ECL) are near 30-day lows while logistics ($UPS, $FDX, $CHRW) have rallied 12-15% in the last month, indicating no market pricing of this bill's risk. Impact score is low at 2 because the bill authorizes zero funding, remains early-stage, and would affect a narrow subset of US-China chemical trade.

Sep 3, 2025

Other Filings by Kelly Louise Morrison

Free — no credit card

Get the next Morrison trade the day it's disclosed

HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →

Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.